Investor Relations & Corp. Communications Mgr.

TG Therapeutics, Inc.; New York (NY); Hybrid; USD 80,000 - 120,000; Full time

Job summary

TG Therapeutics, Inc. in Manhattan, NY and Remote is looking for an Investor Relations and Corporate Communications Manager. You will support strategic communications programs and investor-facing activities, aiding the management of investor relations and corporate messaging.

The ideal candidate will have a Bachelor's degree and over 5 years of experience in corporate communications, with strong skills in Microsoft Office Suite.

TG Therapeutics is committed to diversity and does not sponsor employment visas for this role.

Qualifications

• 5 or more years of experience in corporate communications or investor relations.
• Strong skills in managing multiple projects.
• Professional maturity and discretion in confidential information.

Responsibilities

• Support corporate communications initiatives including press releases.
• Assist in preparing materials for earnings calls and investor conferences.
• Help monitor industry news and analyst coverage.

Skills

Corporate communications

Investor relations

Public relations

Strong written communication

Microsoft Office Suite

Organizational skills

Interpersonal communication

Education

Bachelor’s degree in Communications, Public Relations, or related field

Tools

Microsoft PowerPoint

Microsoft Excel

OneDrive

SharePoint

Job description

Title: Investor Relations and Corporate Communications Manager

Location: Manhattan, NY and Remote

If you are interested in the below position, please send your resume [e-mail] and REFERENCE THE POSITION TITLE within the subject line.

Organizational Overview

TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing‑remitting disease, and active secondary progressive disease, as well as approval by several foreign nations for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. For more information, visit www.TGTherapeutics.com.

Role

TG Therapeutics is seeking a highly motivated and detail‑oriented professional to support both Corporate Communications and Investor Relations initiatives. This individual will play an important role in helping execute strategic communications programs, supporting investor‑facing activities, and ensuring consistent messaging across internal and external stakeholders. This candidate should have strong computer skills and be comfortable working with platforms that will help us monitor both our corporate messaging and investor market intelligence and should understand company modeling.

The ideal candidate is a strong communicator with exceptional organizational skills, intellectual curiosity, and the ability to manage multiple priorities in a fast‑paced public company environment. This role offers the opportunity to gain broad exposure to corporate strategy, executive communications, investor engagement, and commercial‑stage biotechnology operations.

Key Responsibilities

• Support the development and execution of corporate communications initiatives, including press releases, corporate presentations, internal communications, and social media content.
• Assist in preparing materials for quarterly earnings calls, investor conferences, analyst and investor meetings, and other investor‑related activities.
• Assist with the management of analyst modeling
• Coordinate logistics and communications for investor conferences, events, NDRS etc.
• Maintain and update corporate communications materials, including website content, fact sheets and executive biographies
• Help monitor industry news, analyst coverage, competitive activity, and market trends relevant to TG Therapeutics.
• Assist in managing communication calendars, timelines, approvals, and project coordination.

Professional Experience / Qualifications

• Approximately 5 or more years of relevant professional experience in corporate communications, investor relations, public relations, healthcare communications, finance, or related fields preferred.
• Experience within biotechnology, pharmaceutical, healthcare, agency, or public company environments is a plus.
• Strong written, verbal, and interpersonal communication skills.
• Excellent organizational skills with strong attention to detail and the ability to manage multiple projects simultaneously.
• Ability to work effectively in a collaborative, fast‑paced environment.
• Professional maturity and discretion in handling confidential information.
• Strong skills with Microsoft Office Suite (particularly PowerPoint and Excel), Outlook, and shared‑drive systems (OneDrive, SharePoint).
• Experience supporting executive communications, investor relations, public relations, or corporate communications activities preferred.
• Ability to quickly learn and manage multiple industry monitoring platforms
• Interest in biotechnology, healthcare, life sciences, or financial communications strongly preferred.
• Self‑starter with a proactive mindset and willingness to take ownership of projects.

Education

• Bachelor’s degree required, preferably in Communications, Public Relations, Journalism, Business, Finance, Marketing, Life Sciences, or a related field.

Applicants must be currently authorized to work in the United States on a full‑time basis. The company does not sponsor employment visas for this position.

TG Therapeutics is an equal employment opportunity employer, and does not discriminate on the basis of race, color, religion, gender, sexual orientation, gender identity or expression, age, disability, national origin, ancestry, genetic information, military or veteran status, pregnancy or pregnancy‑related condition or any other protected characteristic.